Industry: Service & Software
Published Date: 2025-02-20
Pages: 98 Pages
Report ld: 4020523
Request Sample
Customized Report
The global market for Oncology Automation was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Global health care expenditure currently accounts for approximately 10% of global GDP, and the proportion will continue to increase in the next few years. This is primarily due to the increasing demand for healthcare from an aging population, the rising prevalence of chronic and infectious diseases, and the expansion of emerging markets. The increasing global demand for advanced medical services, advancements in medical technology, growing elderly population, increasing medical expenditures, and increasing awareness of early disease diagnosis and treatment have become the main factors driving the market development, and the market development potential is huge.
This report aims to provide a comprehensive presentation of the global market for Oncology Automation, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Oncology Automation by region & country, by Type, and by Application.
The Oncology Automation market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Automation.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oncology Automation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Oncology Automation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Oncology Automation in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Oncology Automation Product Introduction
1.2 Global Oncology Automation Market Size Forecast (2020-2031)
1.3 Oncology Automation Market Trends & Drivers
1.3.1 Oncology Automation Industry Trends
1.3.2 Oncology Automation Market Drivers & Opportunity
1.3.3 Oncology Automation Market Challenges
1.3.4 Oncology Automation Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oncology Automation Players Revenue Ranking (2024)
2.2 Global Oncology Automation Revenue by Company (2020-2025)
2.3 Key Companies Oncology Automation Manufacturing Base Distribution and Headquarters
2.4 Key Companies Oncology Automation Product Offered
2.5 Key Companies Time to Begin Mass Production of Oncology Automation
2.6 Oncology Automation Market Competitive Analysis
2.6.1 Oncology Automation Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Oncology Automation Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Automation as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 AI
3.1.2 Robotic Process Automation (RPA)
3.1.3 Database Management System
3.1.4 EMR
3.1.5 Others
3.2 Global Oncology Automation Sales Value by Type
3.2.1 Global Oncology Automation Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Oncology Automation Sales Value, by Type (2020-2031)
3.2.3 Global Oncology Automation Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncologists
4.1.2 Pharmacists
4.1.3 Technicians
4.1.4 Nurses
4.2 Global Oncology Automation Sales Value by Application
4.2.1 Global Oncology Automation Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Oncology Automation Sales Value, by Application (2020-2031)
4.2.3 Global Oncology Automation Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Oncology Automation Sales Value by Region
5.1.1 Global Oncology Automation Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Oncology Automation Sales Value by Region (2020-2025)
5.1.3 Global Oncology Automation Sales Value by Region (2026-2031)
5.1.4 Global Oncology Automation Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Oncology Automation Sales Value, 2020-2031
5.2.2 North America Oncology Automation Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Oncology Automation Sales Value, 2020-2031
5.3.2 Europe Oncology Automation Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Oncology Automation Sales Value, 2020-2031
5.4.2 Asia Pacific Oncology Automation Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Oncology Automation Sales Value, 2020-2031
5.5.2 South America Oncology Automation Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Oncology Automation Sales Value, 2020-2031
5.6.2 Middle East & Africa Oncology Automation Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oncology Automation Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Oncology Automation Sales Value, 2020-2031
6.3 United States
6.3.1 United States Oncology Automation Sales Value, 2020-2031
6.3.2 United States Oncology Automation Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Oncology Automation Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Oncology Automation Sales Value, 2020-2031
6.4.2 Europe Oncology Automation Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Oncology Automation Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Oncology Automation Sales Value, 2020-2031
6.5.2 China Oncology Automation Sales Value by Type (%), 2024 VS 2031
6.5.3 China Oncology Automation Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Oncology Automation Sales Value, 2020-2031
6.6.2 Japan Oncology Automation Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Oncology Automation Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Oncology Automation Sales Value, 2020-2031
6.7.2 South Korea Oncology Automation Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Oncology Automation Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Oncology Automation Sales Value, 2020-2031
6.8.2 Southeast Asia Oncology Automation Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Oncology Automation Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Oncology Automation Sales Value, 2020-2031
6.9.2 India Oncology Automation Sales Value by Type (%), 2024 VS 2031
6.9.3 India Oncology Automation Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Radformation
7.1.1 Radformation Profile
7.1.2 Radformation Main Business
7.1.3 Radformation Oncology Automation Products, Services and Solutions
7.1.4 Radformation Oncology Automation Revenue (US$ Million) & (2020-2025)
7.1.5 Radformation Recent Developments
7.2 BD
7.2.1 BD Profile
7.2.2 BD Main Business
7.2.3 BD Oncology Automation Products, Services and Solutions
7.2.4 BD Oncology Automation Revenue (US$ Million) & (2020-2025)
7.2.5 BD Recent Developments
7.3 Oncology Consultants+Samacare
7.3.1 Oncology Consultants+Samacare Profile
7.3.2 Oncology Consultants+Samacare Main Business
7.3.3 Oncology Consultants+Samacare Oncology Automation Products, Services and Solutions
7.3.4 Oncology Consultants+Samacare Oncology Automation Revenue (US$ Million) & (2020-2025)
7.3.5 Oncology Consultants+Samacare Recent Developments
7.4 Mirada
7.4.1 Mirada Profile
7.4.2 Mirada Main Business
7.4.3 Mirada Oncology Automation Products, Services and Solutions
7.4.4 Mirada Oncology Automation Revenue (US$ Million) & (2020-2025)
7.4.5 Mirada Recent Developments
7.5 Datos Health
7.5.1 Datos Health Profile
7.5.2 Datos Health Main Business
7.5.3 Datos Health Oncology Automation Products, Services and Solutions
7.5.4 Datos Health Oncology Automation Revenue (US$ Million) & (2020-2025)
7.5.5 Datos Health Recent Developments
7.6 MIM Software Inc
7.6.1 MIM Software Inc Profile
7.6.2 MIM Software Inc Main Business
7.6.3 MIM Software Inc Oncology Automation Products, Services and Solutions
7.6.4 MIM Software Inc Oncology Automation Revenue (US$ Million) & (2020-2025)
7.6.5 MIM Software Inc Recent Developments
7.7 Elekta AB
7.7.1 Elekta AB Profile
7.7.2 Elekta AB Main Business
7.7.3 Elekta AB Oncology Automation Products, Services and Solutions
7.7.4 Elekta AB Oncology Automation Revenue (US$ Million) & (2020-2025)
7.7.5 Elekta AB Recent Developments
7.8 Varian Medical Systems/Siemens
7.8.1 Varian Medical Systems/Siemens Profile
7.8.2 Varian Medical Systems/Siemens Main Business
7.8.3 Varian Medical Systems/Siemens Oncology Automation Products, Services and Solutions
7.8.4 Varian Medical Systems/Siemens Oncology Automation Revenue (US$ Million) & (2020-2025)
7.8.5 Varian Medical Systems/Siemens Recent Developments
7.9 Philips
7.9.1 Philips Profile
7.9.2 Philips Main Business
7.9.3 Philips Oncology Automation Products, Services and Solutions
7.9.4 Philips Oncology Automation Revenue (US$ Million) & (2020-2025)
7.9.5 Philips Recent Developments
7.10 MedLever Inc
7.10.1 MedLever Inc Profile
7.10.2 MedLever Inc Main Business
7.10.3 MedLever Inc Oncology Automation Products, Services and Solutions
7.10.4 MedLever Inc Oncology Automation Revenue (US$ Million) & (2020-2025)
7.10.5 MedLever Inc Recent Developments
8 Industry Chain Analysis
8.1 Oncology Automation Industrial Chain
8.2 Oncology Automation Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oncology Automation Sales Model
8.5.2 Sales Channel
8.5.3 Oncology Automation Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Oncology Automation was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 110
USD 3950.00
(Single User License)
The global Oncology Automation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 110
USD 2900.00
(Single User License)
The global Oncology Automation market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 125
USD 4900.00
(Single User License)
The global market for Oncology Automation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 76
USD 2900.00
(Single User License)
Market Analysis and Insights: Global Oncology Automation Market
Published Date: 2024-04-11
Pages: 109
USD 4900.00
(Single User License)
The global Oncology Automation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 87
USD 2900.00
(Single User License)
The global market for Oncology Automation was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-06
Pages: 117
USD 3950.00
(Single User License)
The global market for Oncology Automation was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 110
The global Oncology Automation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 110
The global Oncology Automation market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 125
The global market for Oncology Automation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 76
Market Analysis and Insights: Global Oncology Automation Market
Published: 2024-04-11
Pages: 109
The global Oncology Automation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 87
The global market for Oncology Automation was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-06
Pages: 117
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now